B.C. First Nations to acquire an equity interest in Enbridge’s Westcoast Pipeline System

B.C. First Nations to acquire an equity interest in Enbridge's Westcoast Pipeline System GlobeNewswire May 15, 2025 CHILLIWACK, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) — Stonlasec8 Indigenous Alliance Limited Partnership (Stonlasec8), an Indigenous-owned partnership representing 36 First Nations in B.C, announced today it has entered into an agreement to invest approximately CAD$715 million through […]

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire May 15, 2025 PEMGARDA(TM) (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales force PEMGARDA revenue re-acceleration observed in Q2 2025 to date Invivyd continues to target near-term profitability

Bishop Loverde Scholarship Fund at Divine Mercy University, Sterling, VA

Looking to address the increasing mental health needs in dioceses across the US Paul S. Loverde is the beloved Bishop Emeritus of the Diocese of Arlington in Virginia. Appointed by St. John Paul II as the diocese's third bishop, he served for nearly 17 years from 1999 to 2016. In the words ofBishop Michael F.

Rebekah Lusk Named to The Daily Record’s 2025 Power List for Business Law

Recognition among Maryland's most influential business law professionals The Law Office of Lusk Law, LLC is proud to announce that attorney Rebekah Lusk has been named to The Daily Record's 2025 Power List: Business Law edition. This prestigious recognition highlights Rebekah among Maryland's most influential and respected business law practitioners. https://mma.prnewswire.com/media/2687648/Lusk_Law_LLC___Logo.jpg The honorees of The

YARDSTICK INSIGHTS LAUNCHES INNOVATIVE BUSINESS & MARKET INTELLIGENCE PLATFORM

Enables Users To Transform Publicly Available Information Into Actionable Reports Powered By AI Yardstick Insights, Inc. (“Yardstick”), today launched an innovative new data and insights platform developed to empower businesses to better understand and act upon information impacting performance. Yardstick distills massive amounts of publicly available information into straightforward, actionable reports and dashboards powered by

LAZYDAYS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

Lazydays Holdings, Inc. (NasdaqCM: GORV) (“Lazydays,” the “Company” or “we”) today reports financial results for the first quarter ended March 31, 2025. https://mma.prnewswire.com/media/2652243/Lazydays_RV_Logo.jpg Ron Fleming, Interim CEO, said, “We made meaningful progress against our stated priorities in the first quarter of 2025. Our operating results were much improved as compared to our results in the

PureWest Earns “Best Place to Work” Recognition for Third Year Running

PureWest Energy, LLC (“PureWest”), a leading Rocky Mountain independent natural gas producer recognized for its verified low carbon production process, received the Denver Business Journal's “Best Place to Work” recognition in the Large Company category for the third consecutive year. This honor underscores PureWest's sustained commitment to fostering a culture where employees are supported both

Vote NO: Protect the Voices of All Fellows of the AAOS says Kevin Plancher, MD

“We urge all active and emeritus Fellows of the American Academy of Orthopaedic Surgeons (AAOS) to Vote NO on the proposed AAOS Bylaws changes and amendments” says former Chair of the Board of Specialties and a former member of the AAOS Board of Directors (2019-2021), Kevin Plancher, MD, MPH, FAOA, FAAOS. These sweeping changes represent

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire May 15, 2025 PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) — Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, and CLIA laboratory to accelerate oncologic drug discovery and enable drug

Scroll to Top